What does G6PD (Glucose-6-Phosphate Dehydrogenase) stand for?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 7, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

What G6PD Stands For

G6PD stands for Glucose-6-Phosphate Dehydrogenase, an essential enzyme that protects red blood cells from oxidative damage by generating NADPH, which maintains glutathione in its reduced state. 1

Biochemical Function

  • G6PD is the first enzyme of the pentose phosphate pathway, catalyzing the conversion of glucose-6-phosphate to generate NADPH 1, 2
  • NADPH serves as a cofactor for glutathione reductase, converting oxidized glutathione (GSSG) to its reduced form (GSH), which is critical for detoxifying oxidative stress in red blood cells 1
  • The enzyme also produces ribose 5-phosphate necessary for nucleotide synthesis 2

Structural and Genetic Characteristics

  • G6PD exists as a dimer or tetramer consisting of identical subunits, with each subunit containing 515 amino acids and a molecular weight of 59,265 daltons 2
  • The gene encoding G6PD is located on the X chromosome, making deficiency an X-linked recessive disorder that predominantly affects males 3, 2
  • Over 250 genetic variants exist, with approximately 73 variants having identified mutations—most resulting from single or double nucleotide substitutions 2

Clinical Significance

  • G6PD deficiency is the most common enzymatic disorder of red blood cells worldwide, affecting an estimated 400 million people 4, 2
  • Erythrocytes are particularly vulnerable because they lack mitochondria and peroxisomes yet are hemoglobin- and iron-filled containers exposed to high oxidative stress from oxygen transport 1
  • Deficiency causes red blood cells to be susceptible to hemolysis when exposed to oxidative stressors including certain medications (dapsone, primaquine, methylene blue), infections, and fava beans 1, 5, 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

[Glucose-6-phosphate dehydrogenase].

Nihon rinsho. Japanese journal of clinical medicine, 1995

Guideline

Medications Contraindicated in G6PD Deficiency

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.